Objective measurement of allergic reactions in the eye

Current Opinion in Allergy and Clinical Immunology

Volumn 4, Issue 5, 2004, Pages 447-453

  Friedlaender, Mitchell H ^a  

^a SCRIPPS CLINIC   (United States)

Author keywords

Allergic conjunctivitis; Conjunctival allergen challenge; Conjunctival provocation test; Ocular allergy

Indexed keywords

ALLERGEN; ANTIALLERGIC AGENT; ANTIINFLAMMATORY AGENT;

ALLERGIC REACTION; ALLERGY TEST; CHEMOSIS; CLINICAL STUDY; COLORIMETER; CONJUNCTIVA; DEVICE; DIAGNOSTIC TEST; DRUG EFFICACY; ERYTHEMA; EYE DISEASE; EYE INFLAMMATION; HUMAN; MEASUREMENT; OCULAR PRURITUS; PRIORITY JOURNAL; REVIEW; SENSATION; SLIT LAMP; SPECTRORADIOMETER;

ALLERGENS; CONJUNCTIVITIS, ALLERGIC; EDEMA; ERYTHEMA; HUMANS; POLLEN; TOUCH;

EID: 4644229900     PISSN: 15284050     EISSN: None     Source Type: Journal    
DOI: 10.1097/00130832-200410000-00019     Document Type: Review

References (31)

1. Blackley CH. Experimental researches on the cause and nature of catarrhous acativas. In: Hay Fever or Hay Asthma. London: Bailliere, Tindal, Cox, Ltd; 1873.
2. Noon L. Prophylactic inoculation against hay fever. Lancet 1911; 1:1572.
3. Peshkin MM. A dry pollen ophthalmic test in pollen asthma and hayfever patients negative to cutaneous tests. J Allergy 1931; 3:20-29.
4. Tuft L, Tornsey PJ, Ettelson LN, Heck VN. Ophthalmic and nasal mucosal testing as an aid in the determination of house dust allergy. J Allergy 1962; 33:448-457.
5. Ciprandi G, Pronzato C, Ricca V, et al. Allergen-specific challenge induces intercellular adhesion molecule 1 (ICAM-1 or CD54) on nasal epithelial cells in allergic subjects. Relationships with early and late inflammatory phenomena. Am J Respir Crit Care Med 1994; 150:1653-1659.
6. Moller C, Bjorksten B, Nilsson G, Dreborg S. The precision of the conjunctival provocation test. Allergy 1984; 39:37-41.
7. Abelson M, Chambers WA, Smith LM. Conjunctival allergen challenge. A clinical approach to studying allergic conjunctivitis. Arch. Ophthalmol 1990; 108:84-88.
8. Bonini S, Bonini S, Bucci MG, et al. Allergen dose response and late symptoms in a human model of ocular allergy. J Allergy Clin Immunol 1990; 86:869-876.
9. Allansmith MR, Baird RS, Greiner JV, Bloch KJ. Late-phase reactions in ocular anaphylaxis in the rat. J Allergy Clin Immunol 1984; 76:49-55.
10. Jackson WB, O'Connor GR, Hall JM. Plate hemolysin test for the rapid screening of Toxoplasma antibodies [abstract]. Appl Microbiol 1974; 27:896.
11. Calonge M, Briggs RM, Levene RB, et al. Early and late phases of ocular anaphylaxis in actively immunized guinea pigs. Acta Opthalmol (Copenh) 1990; 68:470-476.
12. Leonardi A, Secchi AG, Briggs R, Allansmith MR. Conjunctival mast cells and the allergic late phase reaction. Ophthalmic Res 1992; 24:234-242.
13. Leonardi A, Borghesan F, Faggian D, et al. Tear and serum soluble leukocyte activation markers in conjunctival allergic diseases. Am J Ophthalmol 2000; 129:151-158.
14. Woodward DF, Nieves AL, Hawley SB, et al. The pruritogenic and inflammatory effects of prostanoids in the conjunctiva. J Ocul Pharmacol Ther 1995; 11:339-347.
15. Margrini L, Bonini S, Centofanti M, et al. Tear tryptase levels and allergic conjunctivitis. Allergy 1996; 51:577-581.
16. Bonini S, Magrini L, Rotiroti G, et al. The eosinophil and the eye. Allergy 1997; 52:44-47.
17. Vesaluoma M, Rosenberg ME, Teppo A, et al. Tumour necrosis factor alpha (TNF alpha) in tears of atopic patients after conjunctival allergen challenge. Clin Exp Allergy 1999; 29:537-542.
18. Anderson DF, MacLeod JD, Baddeley SM, et al. Seasonal allergic conjunctivitis is accompanied by increased mast cell numbers in the absence of leucocyte infiltration. Clin Exp Allergy 1997; 27:1060-1066.
19. Friedlaender MH, Harris J, LaVallee N, et al. Evaluation of the onset and duration of effect of azelastine eye drops (0.05%) versus placebo in patients with allergic conjunctivitis using an allergen challenge model. Ophthalmology 2000; 107:2152-2157.
20. Foster CS. The Cromolyn Sodium Collaborative Study Group: Evaluation of topical cromolyn sodium in the treatment of vernal keratoconjunctivitis. Ophthalmology 1988; 95:194-201.
21. Ahuluwalia P, Anderson DF, Wilson SJ, et al. Nedocromil sodium and levocabastine reduce the symptoms of conjunctival allergen challenge by different mechanisms. J Allergy Clin Immunol 2001; 108:449-454.
22. Netland PA, Leahy C, Krenzer KL. Emedastine ophthalmic solution 0.05% versus levocabastine ophthalmic suspension 0.05% in the treatment of allergic conjunctivitis using the conjunctival allergen challenge model. Am J Ophthalmol 2000; 130:717-723.
23. Abram LE. An evaluation of conjunctival testing in extrinsic respiratory allergy. J Allergy 1949; 20:66-69.
24. Tuft L. The value of eye tests with inhalant allergens: A clinical study. Ann Allergy 1967; 25:183-191.
25. Friedlaender MH. Conjunctival provocation tests: A model of human ocular allergy. Trans Am Ophthalmol Soc 1989; 87:577-597.
26. Abelson MB, Chapin MJ, Kapik BM, Shams NB. Efficacy of ketotifen fumarate 0.025% ophthalmic solution compared with placebo in the conjunctival allergen challenge model. Arch. Ophthalmol 2003; 121:626-630. This study demonstrated the rapid onset and long duration of action of ketotifen in CAC.
27. Abelson MB, Loeffler O. Conjunctival allergen challenge: Models in the investigation of ocular allergy. Curr Allergy Asthma Rep 2003; 3:363-368.
28. Greiner JV, Mundorf T, Dubiner H, et al. Efficacy and safety of ketotifen fumarate 0.025% in the conjunctival antigen challenge model of ocular allergic conjunctivitis. Am J Ophthalmol. 2003; 136:1097-1105. This large, multicenter study demonstrated good efficacy for ketotifen in ocular allergy.
29. Friedlaender MH. Conjunctival provocation testing: Overview of recent clinical trials in ocular allergy. Int Ophthalmol Clin 2003; 43:95-104. This is a comprehensive review of conjunctival provocation testing and discussion of recent clinical trials that used this model of ocular allergy.
30. Abelson M, Loeffler O. Conjunctival allergen challenge: Models in the investigation of ocular allergy. Curr Allergy Asthma Rep 2003; 3:363-368. This is a review of the science of CAC and the design of clinical trials.
31. Asbell PA, Ahmad SM. Diagnostic assays in ocular allergy. Int Ophthalmol Clin 2003; 43:83-93. These authors present a discussion of diagnostic tests for ocular allergy including in-vitro and in-vivo studies.